r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

KK

Kevin Koch

Insider · President and CEO · EWTX

Kevin Koch files insider transactions with the SEC as a president and ceo of Edgewise Therapeutics (EWTX). We hold 1 disclosed purchase or sale filed since 22 February 2006, 1 of them in the last 90 days.

  • Files forEWTX
  • Disclosed buys and sells1 in all, 1 in the last 90 days
  • Last disclosure14 August 2026

Positions held

3 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 17 August 2021 — 12 August 2026President and CEO · Edgewise Therapeutics (EWTX)38 Form 4 lines · source: SEC Form 4
  • Filed 28 June 2017 — 21 May 2020Director · Miragen Therapeutics (MGEN)4 Form 4 lines · source: SEC Form 4
  • Filed 17 February 2006 — 24 July 2013President, CSO · Array Biopharma (ARRY)21 Form 4 lines · source: SEC Form 4

Everything they disclosed

63 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.